XOMA Royalty (XOMA) Revenue Growth (3y) (2014 - 2026)
XOMA Royalty (XOMA) Revenue Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 204.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 204.34% |
| Dec 31, 2025 | 152.95% |
| Jun 30, 2025 | 112.32% |
| Mar 31, 2025 | 13.30% |
| Dec 31, 2024 | 35.72% |
| Sep 30, 2024 | 135.65% |
| Jun 30, 2024 | 77.34% |
| Mar 31, 2024 | 58.39% |
| Dec 31, 2023 | -63.88% |
| Sep 30, 2023 | -26.08% |
| Jun 30, 2023 | 215.09% |
| Mar 31, 2023 | -4.39% |
| Dec 31, 2022 | 26.29% |
| Sep 30, 2022 | -62.93% |
| Jun 30, 2022 | -18.28% |
| Mar 31, 2022 | -30.33% |
| Dec 31, 2021 | -50.86% |
| Sep 30, 2021 | -15.01% |
| Jun 30, 2021 | -26.35% |
| Dec 31, 2020 | 72.67% |